SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : Speculating in Takeover Targets
ULBI 6.110+2.7%3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Labrador who wrote (5143)3/11/2019 1:11:49 PM
From: richardred   of 7255
 
This massive acquisition most definitely caught my attention. Personally I have mixed feelings. IMO good for Celgene holders not so much for BMY holders near term. With thoughts of falling behind competitors in oncology. I feel BMY felt they had to make the big plunge acquisition because their was nothing available in oncology, in scale to be a leader. Celgene already built itself through big and small acquisitions. This took much off the market. It seems some of BMY holders are not happy about the deal. Of course, I could be wrong, but I think the deal gets approved. Celgene already has scale in the Cancer field with approved products and is very profitable with good cash flow. Good luck in your mission. Current 17%-18% gain on a 50 BMY price & 50 in cash.

From: richardred1/3/2019 9:53:02 AM

 Read Replies (1) of 5143
Major Acquisition to start the new year. The same way last year started.

Bristol-Myers to buy Celgene in $74B deal

cnbc.com

From: richardred1/22/2018 11:16:51 AM

 Read Replies (1) of 5112

A Merger Monday. Mainly in the Bio-Pharma space.

Juno Therapeutics acquired by Celgene for $9B in dramatic deal for rising biotech star.
geekwire.com

Sanofi digs deep to buy U.S. hemophilia group Bioverativ for $11.6 billion
reuters.com

AIG to Acquire Validus for $5.56 Billion in Cash

businesswire.com
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News